Daniel J Powell

19PUBLICATIONS
145CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 30, 2026
Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability Tradeoffs.

|Oct 16, 2025
A Novel Early Memory-Enriched Allogeneic NKG2D CAR-T Cell Therapy Based on CRISPR/Cas9 Technology for Solid Tumors.

Cristina Aparicio, Mónica Queipo, Marina Belver

|Jan 27, 2025
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas.

Priyanka Sehgal, Ammar S Naqvi, Makenna Higgins

|Jul 19, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

Ruchi P Patel, Guido Ghilardi, Yunlin Zhang

|Oct 26, 2023
A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression.

Sarah B Gitto, Margaret Whicker, Gareth Davies

|Sep 22, 2023
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer.

Sara Bobisse, Valentina Bianchi, Janos L Tanyi

Pageof 4

Frequent Collaborators

4 joint publications

Lana E Kandalaft

3 joint publications

Alexandre Harari

2 joint publications

George Coukos

2 joint publications

Raphael Genolet